What is already known on this subject? Hepatic inflammatory angiomyolipoma is a rare and easily misdiagnosed disease, lacking systematic summaries.
What are the new findings? Analysis of all reported cases provides thorough information regarding clinical manifestations, diagnoses, treatments, and prognoses.
How might it impact clinical practice in the foreseeable future? Better understanding of this disease will reduce misdiagnosis and guide treatment.